Meconium stained amniotic fluid exposure and long-term respiratory morbidity in the offspring
- PMID: 33730429
- DOI: 10.1002/ppul.25357
Meconium stained amniotic fluid exposure and long-term respiratory morbidity in the offspring
Abstract
Objective: Meconium stained amniotic fluid (MSAF) is a well-established risk factor for neonatal short-term respiratory complications. Little is known regarding the long-term morbidity. We investigated the possible association between MSAF and offspring respiratory morbidity.
Methods: A population-based, cohort study of singleton deliveries occurring between 1991 and 2014 at a sole regional tertiary medical center was performed. Incidence of offspring respiratory related hospitalizations up to the age of 18 years were evaluated and compared to unexposed offspring. A Kaplan-Meier survival curve was used to compare cumulative respiratory morbidity incidence, and a Cox proportional hazards model was used to control for confounders.
Results: During the study period 242,342 deliveries met the inclusion criteria. Of them, 14.7% (n = 35,609) were complicated with MSAF. Incidence of respiratory-related hospitalizations was significantly lower in children exposed to MSAF as compared to the unexposed group (4.5% vs. 4.9%, respectively; p < .01). Specifically, hospitalizations involving pneumonitis were significantly less common among the MSAF group (odds ratio, 0.35; 95% confidence interval [95% CI], 0.13-0.96; p = .03). The Kaplan-Meier survival curve demonstrated significantly lower total cumulative respiratory morbidity rates in the MSAF exposed group (log rank p < .01). In the Cox model, controlled for clinically relevant confounders, MSAF exhibited an independent and significant protective effect on long-term childhood respiratory morbidity (aHR, 0.91; 95% CI, 0.86-0.96; p < .01).
Conclusions: Fetal exposure to MSAF during labor appears to be associated with lower rates of long-term respiratory related hospitalizations in the offspring. Changes in offspring microbiome, as well as functional and anatomical modulations possibly resulting from MSAF exposure, might offer a plausible explanation of our findings.
Keywords: follow-up; meconium stain amniotic fluid; pediatric hospitalization; population-based cohort; respiratory diseases.
© 2021 Wiley Periodicals LLC.
References
REFERENCES
-
- Mitchell S , Chandraharan E. Meconium-stained amniotic fluid. Obstet Gynaecol Reprod Med. 2018;28:120-124.
-
- Unsworth J , Vause S. Meconium in labour. Obstet Gynaecol Reprod Med. 2010;20(10):289-294.
-
- Maoz O , Wainstock T , Sheiner E , Walfisch A. Immediate perinatal outcomes of postterm deliveries. J Maternal-Fetal Neonatal Med. 2018:1-6.
-
- Hiersch L , Krispin E , Linder N , et al. Meconium-stained amniotic fluid and neonatal morbidity in low-risk pregnancies at term: the effect of gestational age. Am J Perinatol. 2017;34(02):183-190.
-
- Hutton EK , Thorpe J. Consequences of meconium stained amniotic fluid: what does the evidence tell us? Early Hum Dev. 2014;90(7):333-339.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous